Development and Validation of the Promising PPAR Signaling Pathway-Based Prognostic Prediction Model in Uterine Cervical Cancer

Figure 6

(a) The GSVA analysis based on the KEGG terms; (b) the GSVA analysis based on the Hallmark terms; (c) the GO BP enrichment analysis; (d) the GO CC enrichment analysis; (e) the GO MF enrichment analysis.

(a)

(b)

(c)

(d)

(e)